Nasdaq:US$13.20 (+0.00) | HKEX:HK$20.25 (-0.45) | AIM:£2.19 (+0.01)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor